Skip to content

Application of Dexmedetomidine Sedation Anesthesia in Endoscopic Dacryocystorhinostomy

Application of Dexmedetomidine Sedation Anesthesia in Endoscopic Dacryocystorhinostomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123204
Enrollment
Unknown
Registered
2026-04-22
Start date
2021-08-04
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Dacryocystitis

Interventions

Group D:Continuous infusion of dexmedetomidine
Group C:Continuous pump infusion of 0.9% sodium chloride solution at the same volume and rate as group D

Sponsors

Shanxi Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed as having chronic dacryocystitis requiring En-DCR; 2. Had an ASA physical status of ?–?; 3. Had a NYHA functional class of ?–?; 4. Aged 40–70 years.

Exclusion criteria

Exclusion criteria: 1. NYHA functional class ?–?; 2. Pulmonary function tests indicating severe obstructive ventilatory dysfunction, positive bronchial provocation test, or intermittent asthma episodes without regular treatment; 3. Blood pressure (BP) >=180/105 mmHg; or fasting blood glucose >8 mmol/L; 4. Significant hepatic or renal dysfunction; 5. Withdrawal of anticoagulant medication for less than 7 days; 6. Cognitive impairment or inability to cooperate with medical procedures.

Design outcomes

Primary

MeasureTime frame
Mean Arterial Pressure (MAP);

Secondary

MeasureTime frame
Heart rate (HR);Respiratory rate (RR);Norepinephrine (NE);Cortisol (Cor);Interleukin-6 (IL-6);

Countries

China

Contacts

Public ContactRui Rui

Shanxi Eye Hospital

490676346@qq.com+86 136 2345 2811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026